Kovitz Investment Group Partners LLC acquired a new stake in Tenet Healthcare Co. (NYSE:THC - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,347 shares of the company's stock, valued at approximately $422,000.
Other large investors also recently bought and sold shares of the company. GeoWealth Management LLC boosted its stake in Tenet Healthcare by 39.8% during the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after purchasing an additional 84 shares during the period. WR Wealth Planners LLC raised its stake in shares of Tenet Healthcare by 2,836.4% during the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after purchasing an additional 312 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Tenet Healthcare by 30.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock worth $59,000 after buying an additional 110 shares in the last quarter. Kestra Investment Management LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at $60,000. Finally, Wilmington Savings Fund Society FSB raised its holdings in Tenet Healthcare by 1,352.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock worth $66,000 after buying an additional 487 shares during the period. Institutional investors own 95.44% of the company's stock.
Insider Buying and Selling at Tenet Healthcare
In related news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now owns 27,378 shares in the company, valued at $3,434,022.54. This represents a 25.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.81% of the company's stock.
Tenet Healthcare Stock Down 0.5 %
Shares of NYSE:THC traded down $0.69 on Wednesday, reaching $150.79. The company had a trading volume of 201,747 shares, compared to its average volume of 1,539,327. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The stock has a market capitalization of $14.01 billion, a P/E ratio of 4.68, a P/E/G ratio of 1.02 and a beta of 1.63. The stock has a 50-day moving average price of $127.86 and a 200 day moving average price of $136.11. Tenet Healthcare Co. has a twelve month low of $109.82 and a twelve month high of $171.20.
Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The firm had revenue of $5.22 billion during the quarter, compared to analysts' expectations of $5.15 billion. During the same quarter in the prior year, the business earned $3.22 earnings per share. The company's revenue was down 2.5% on a year-over-year basis. On average, equities analysts expect that Tenet Healthcare Co. will post 12.24 EPS for the current year.
Analyst Ratings Changes
Several equities research analysts recently commented on the stock. The Goldman Sachs Group upped their price target on shares of Tenet Healthcare from $134.00 to $154.00 and gave the company a "neutral" rating in a research report on Monday. Baird R W cut Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays upped their price target on Tenet Healthcare from $161.00 to $171.00 and gave the company an "overweight" rating in a research report on Wednesday, April 30th. StockNews.com raised Tenet Healthcare from a "hold" rating to a "buy" rating in a research note on Thursday, May 1st. Finally, Guggenheim assumed coverage on shares of Tenet Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $165.00 price target for the company. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $173.69.
Check Out Our Latest Stock Report on Tenet Healthcare
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
